- Home
- KVHI vs COEP Comparison
KVHI vs COEP Comparison
Compare KVHI & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KVHI | COEP |
|---|---|---|
| Founded | 1978 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.2M | 100.4M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | KVHI | COEP |
|---|---|---|
| Price | $6.00 | $16.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 53.9K | ★ 64.8K |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $107,407,000.00 | $500,996.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.15 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.69 | $2.31 |
| 52 Week High | $6.41 | $21.41 |
Technical Indicators
Market Signals| Indicator | KVHI | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 55.47 | 51.18 |
| Support Level | $5.89 | $15.40 |
| Resistance Level | $6.10 | $21.41 |
| Average True Range (ATR) | 0.26 | 1.56 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 82.83 | 32.02 |
Price Performance
Historical ComparisonAbout KVHI KVH Industries Inc.
KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.